Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.

Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.